Physiotherapy in Motion Multispeciality Research Group (PTinMOTION), Department of Physiotherapy, University of Valencia, Valencia, Spain.
Department of Physical Therapy, Faculty of Medicine, University of Chile, Santiago, Chile.
Pain. 2024 Jun 1;165(6):1196-1206. doi: 10.1097/j.pain.0000000000003126. Epub 2023 Nov 30.
Pain neuroscience education (PNE) has shown promising results in the management of patients with chronic spinal pain (CSP). However, no previous review has determined the optimal dose of PNE added to an exercise programme to achieve clinically relevant improvements. The aim was to determine the dose-response association between PNE added to an exercise programme and improvements in pain intensity and disability in patients with CSP. A systematic search of PubMed/MEDLINE, Embase, Web of Science, Scopus, and the Cochrane Library was conducted from inception to April 19, 2023. The exposure variable (dosage) was the total minutes of PNE. Outcome measures included pain intensity, disability, quality of life, pressure pain thresholds, and central sensitization inventory. Data extraction, risk-of-bias assessment, and certainty of evidence were performed by 2 independent reviewers. The dose-response relationship was assessed using a restricted cubic spline model. Twenty-six randomised controlled trials with 1852 patients were included. Meta-analysis revealed a statistically significant effect in favour of PNE on pain intensity and disability. In addition, a dose of 200 and 150 minutes of PNE added to an exercise programme was estimated to exceed the minimum clinically important difference described in the literature for pain intensity (-2.61 points, 95% CI = -3.12 to -2.10) and disability (-6.84 points, 95% CI = -7.98 to -5.70), respectively. The pooled effect of the isolated exercise was small. These findings may be useful in optimising the most appropriate PNE dose to achieve clinically relevant improvements in patients with CSP.
疼痛神经科学教育(PNE)在慢性脊柱疼痛(CSP)患者的管理中显示出有希望的结果。然而,以前的综述尚未确定将 PNE 添加到运动方案中以实现临床相关改善的最佳剂量。本研究旨在确定将 PNE 添加到运动方案中与 CSP 患者的疼痛强度和残疾改善之间的剂量-反应关联。从开始到 2023 年 4 月 19 日,对 PubMed/MEDLINE、Embase、Web of Science、Scopus 和 Cochrane 图书馆进行了系统检索。暴露变量(剂量)是 PNE 的总分钟数。结局指标包括疼痛强度、残疾、生活质量、压力疼痛阈值和中枢敏化量表。数据提取、偏倚风险评估和证据确定性由 2 名独立评审员进行。使用限制性立方样条模型评估剂量-反应关系。纳入了 26 项随机对照试验,共 1852 名患者。荟萃分析显示,PNE 对疼痛强度和残疾有统计学上的显著影响。此外,估计将 200 和 150 分钟的 PNE 添加到运动方案中,分别超过了文献中描述的疼痛强度(-2.61 分,95%CI=-3.12 至-2.10)和残疾(-6.84 分,95%CI=-7.98 至-5.70)的最小临床重要差异。单独运动的综合效果较小。这些发现可能有助于优化最合适的 PNE 剂量,以实现 CSP 患者的临床相关改善。